Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Fischer Medical Ventures's Enterprise Value is ₹26,014 Mil.
Fischer Medical Ventures's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was ₹522 Mil. Therefore, Fischer Medical Ventures's EV-to-EBIT ratio for today is 49.84.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Fischer Medical Ventures (BOM:524743) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Fischer Medical Ventures's EV-to-EBIT for today is
Fischer Medical Ventures's current Enterprise Value is ₹26,014 Mil.
Fischer Medical Ventures's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹522 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Fischer Medical Ventures's EV-to-EBITDA for today is:
Fischer Medical Ventures's current Enterprise Value is ₹26,014 Mil.
Fischer Medical Ventures's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹552 Mil.
Fischer Medical Ventures's current Enterprise Value is ₹26,014 Mil.
Fischer Medical Ventures's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹3,086 Mil.
Fischer Medical Ventures's current Enterprise Value is ₹26,014 Mil.
Fischer Medical Ventures's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.
Fischer Medical Ventures's current Enterprise Value is ₹26,014 Mil.
Fischer Medical Ventures's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fischer Medical Ventures Enterprise Value Related Terms
Fischer Medical Ventures Enterprise Value Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:524743 vs ABT, SYK, MDT: Enterprise Value Comparison
For the Medical Devices subindustry, Fischer Medical Ventures's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fischer Medical Ventures Enterprise Value vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Fischer Medical Ventures's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Fischer Medical Ventures's Enterprise Value falls into.
Fischer Medical Ventures Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Fischer Medical Ventures's Enterprise Value for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fischer Medical Ventures (BOM:524743) has a Enterprise Value of ₹26,014 Mil as of Jul. 16, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Fischer Medical Ventures and its competitors.
Is Fischer Medical Ventures' Enterprise Value too high?
Fischer Medical Ventures' current Enterprise Value is ₹26,014 Mil. Overall, Fischer Medical Ventures has a GF Score™ of 40/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Fischer Medical Ventures' Enterprise Value compare to ABT and SYK?
Fischer Medical Ventures' Enterprise Value of ₹26,014 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Medical Devices & Instruments company?
A good Enterprise Value depends on the Medical Devices & Instruments industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Fischer Medical Ventures and its competitors. Fischer Medical Ventures's current Enterprise Value is ₹26,014 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fischer Medical Ventures stock overvalued right now?
Based on GuruFocus' analysis, Fischer Medical Ventures (BOM:524743) is currently considered Possible Value Trap. The stock's GF Value™ is ₹219.32, compared to a current price of ₹38.58 — trading 82.4% below its estimated fair value. The current Enterprise Value is ₹26,014 Mil. Fischer Medical Ventures' overall GF Score™ is 40/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Fischer Medical Ventures (BOM:524743), the current Enterprise Value is ₹26,014 Mil as of Jul. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fischer Medical Ventures (BOM:524743) Overvalued in 2026?
Based on GuruFocus' analysis, Fischer Medical Ventures stock appears to be undervalued.
The current stock price of ₹38.58 is trading 82.4% below its estimated GF Value™ of ₹219.32.
GuruFocus considers Fischer Medical Ventures to be Possible Value Trap.
Key valuation signals for BOM:524743:
Enterprise Value: ₹26,014 Mil
GF Value™: ₹219.32 vs. price of ₹38.58 (82.4% below fair value)
No single metric tells the full story. See the BOM:524743 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fischer Medical Ventures Ltd is engaged in developing and trading of Medical Equipment including cutting-edge Magnetic Resonance Imaging (MRI) systems in India.
40GF Score
Get the complete analysis for BOM:524743
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524743 has been successfully added to your 
